581 related articles for article (PubMed ID: 29110162)
21. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
22. Extra-esophageal gastroesophageal reflux disease and asthma: understanding this interplay.
Naik RD; Vaezi MF
Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):969-82. PubMed ID: 26067887
[TBL] [Abstract][Full Text] [Related]
23. Gastroesophageal reflux disease: exaggerations, evidence and clinical practice.
Ferreira CT; Carvalho Ed; Sdepanian VL; Morais MB; Vieira MC; Silva LR
J Pediatr (Rio J); 2014; 90(2):105-18. PubMed ID: 24184302
[TBL] [Abstract][Full Text] [Related]
24. Management of refractory typical GERD symptoms.
Scarpellini E; Ang D; Pauwels A; De Santis A; Vanuytsel T; Tack J
Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):281-94. PubMed ID: 27075264
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
26. Management of Gastroesophageal Reflux Disease.
Gyawali CP; Fass R
Gastroenterology; 2018 Jan; 154(2):302-318. PubMed ID: 28827081
[TBL] [Abstract][Full Text] [Related]
27. Medical therapy for gastroesophageal reflux disease.
Arora AS; Castell DO
Mayo Clin Proc; 2001 Jan; 76(1):102-6. PubMed ID: 11155401
[TBL] [Abstract][Full Text] [Related]
28. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease.
Storr M; Meining A; Allescher HD
Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061
[TBL] [Abstract][Full Text] [Related]
29. [Underlying Mechanisms and Management of Refractory Gastroesophageal Reflux Disease].
Lee KJ
Korean J Gastroenterol; 2015 Aug; 66(2):70-4. PubMed ID: 26289239
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological management of gastroesophageal reflux disease in infants: current opinions.
El-Mahdy MA; Mansoor FA; Jadcherla SR
Curr Opin Pharmacol; 2017 Dec; 37():112-117. PubMed ID: 29128854
[TBL] [Abstract][Full Text] [Related]
31. The pharmacological management of gastroesophageal reflux disease.
Lowe RC; Wolfe MM
Minerva Gastroenterol Dietol; 2004 Sep; 50(3):227-37. PubMed ID: 15729198
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology and pharmacological treatment of gastroesophageal reflux disease.
Storr M; Meining A; Allescher HD
Dig Dis; 2000; 18(2):93-102. PubMed ID: 11060472
[TBL] [Abstract][Full Text] [Related]
33. HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.
Zaterka S; Marion SB; Roveda F; Perrotti MA; Chinzon D
Arq Gastroenterol; 2019 Aug; 56(2):202-208. PubMed ID: 31460587
[TBL] [Abstract][Full Text] [Related]
34. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
36. Partnership in optimizing management of reflux symptoms: a treatment algorithm for over-the-counter proton-pump inhibitors.
Boardman HF; Delaney BC; Haag S
Curr Med Res Opin; 2015; 31(7):1309-18. PubMed ID: 25950642
[TBL] [Abstract][Full Text] [Related]
37. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
[TBL] [Abstract][Full Text] [Related]
38. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
39. Evolving pharmacological approaches in gastroesophageal reflux disease.
Altan E; Blondeau K; Pauwels A; Farré R; Tack J
Expert Opin Emerg Drugs; 2012 Sep; 17(3):347-59. PubMed ID: 22834684
[TBL] [Abstract][Full Text] [Related]
40. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
